The organizations are kicking off research projects in the US and UK using the latest technologies to study epilepsy and the impact of hospital interventions through Artificial Intelligence and Quantum Computing.
Cleveland Clinic, IBM and the Science and Technology Facilities Council’s (STFC) Hartree Centre in the UK have announced an innovative collaboration aimed at advancing healthcare and biomedical science through advanced computing technologies, including artificial intelligence (AI) and quantum computing. Two clinical research projects have been launched to kick-start the new collaboration. They will be led by Dr. Jehi, an epilepsy researcher, and Charles Knowles, Ph.D., Chief Academic Officer at Cleveland Clinic London, working closely with teams from IBM and Hartree Centre. The projects will be supported by the Hartree National Centre for Digital Innovation, a collaboration between IBM and Hartree Centre.
“This international collaboration brings together a multidisciplinary team of scientists, clinical researchers and physicians from across industry, government and healthcare. The research teams will leverage high performance and quantum computing to advance life sciences, with the goal of improving healthcare and accelerating new treatments for patients around the world. Cleveland Clinic London will be a central link between innovative clinical care in the UK and Cleveland Clinic’s global footprint,” said Lara Jehi, M.D, MHCDS, Chief Research Information Officer, Cleveland Clinic.
“This partnership will play an important role in advancing research into the use of cutting-edge computation in healthcare and life sciences. We look forward to working with researchers from Cleveland Clinic London and the Hartree Centre to explore promising areas of discovery across quantum computing, AI and beyond,” said Alessandro Curioni, IBM Fellow and Director, IBM Research Zurich.
The first project, led by Dr. Knowles and supported by the Hartree National Centre for Digital Innovation, will apply advanced AI tools to objectively quantify the impact of care on patients at Cleveland Clinic London. Researchers from IBM, Hartree Centre and Cleveland Clinic will examine how common hospital procedures affect a patient’s overall health and quality of life, with the goal of enhancing patient outcomes. The second project, led by Dr. Jehi in collaboration with IBM and the Hartree Centre, will apply quantum computing to analyze large-scale data sets to identify molecular features in the body that better predict surgical response in patients with epilepsy. The objective is to uncover novel biomarkers that can be used to personalize treatment plans and improve patient outcomes.
